Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients \> 18 years
Male or female patients. Female patients must have been either post-menopausal for one year, surgically sterile, or using effective contraceptive methods
Patients with essential hypertension, previously treated with an antihypertensive single-drug therapy, either uncontrolled or intolerant.
BP thresholds at visit 1:
* For patients previously treated and uncontrolled: 140≤ office SBP\<180 mmHg
* For patients previously treated, controlled but intolerant: office SBP≥130 mmHg
BP thresholds at visit 2 (for all patients):
* 160≤office SBP\<180 mmHg AND
* 155≤home SBP\<175 mmHg (3-day period of home blood pressure monitoring just before randomization)
You may not be if
Women of child-bearing potential not using any effective methods of contraception
Severe hypertension (office BP ≥ 180/110 mmHg)
Impossibility to stop abruptly previous antihypertensive treatments at visit 1
Patients previously untreated or patients treated with two or three antihypertensive medications
History or evidence of a secondary form of hypertension
History of hypersensitivity to ACEi or renin inhibitors
History of heart failure, stroke or coronary heart disease